PT3023110T - Solução para secagem por pulverização que compreende acetato succinato de hipromelose e método para produzir dispersão sólida - Google Patents

Solução para secagem por pulverização que compreende acetato succinato de hipromelose e método para produzir dispersão sólida

Info

Publication number
PT3023110T
PT3023110T PT151949831T PT15194983T PT3023110T PT 3023110 T PT3023110 T PT 3023110T PT 151949831 T PT151949831 T PT 151949831T PT 15194983 T PT15194983 T PT 15194983T PT 3023110 T PT3023110 T PT 3023110T
Authority
PT
Portugal
Prior art keywords
solution
spray drying
solid dispersion
acetate succinate
producing solid
Prior art date
Application number
PT151949831T
Other languages
English (en)
Inventor
Warashina Shogo
Kusaki Fumie
Kikuchi Kazuki
Obara Sakae
Maruyama Naosuke
Original Assignee
Shinetsu Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55083271&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3023110(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shinetsu Chemical Co filed Critical Shinetsu Chemical Co
Publication of PT3023110T publication Critical patent/PT3023110T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
PT151949831T 2014-11-18 2015-11-17 Solução para secagem por pulverização que compreende acetato succinato de hipromelose e método para produzir dispersão sólida PT3023110T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014233774A JP6203702B2 (ja) 2014-11-18 2014-11-18 ヒプロメロース酢酸エステルコハク酸エステルを用いたスプレードライ用溶液及び固体分散体の製造方法

Publications (1)

Publication Number Publication Date
PT3023110T true PT3023110T (pt) 2017-09-04

Family

ID=55083271

Family Applications (1)

Application Number Title Priority Date Filing Date
PT151949831T PT3023110T (pt) 2014-11-18 2015-11-17 Solução para secagem por pulverização que compreende acetato succinato de hipromelose e método para produzir dispersão sólida

Country Status (6)

Country Link
US (1) US10493161B2 (pt)
EP (1) EP3023110B2 (pt)
JP (1) JP6203702B2 (pt)
KR (2) KR102315569B1 (pt)
CN (1) CN105597103B (pt)
PT (1) PT3023110T (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106265526A (zh) * 2016-09-22 2017-01-04 山东大学 一种抗真菌药物泊沙康唑的固体分散体及制备方法与应用
US10888525B2 (en) 2016-11-02 2021-01-12 Shin-Etsu Chemical Co., Ltd. Hypromellose acetate succinate and method for producing the same
CA3050696A1 (en) * 2017-01-20 2018-07-26 Constellation Pharmaceuticals, Inc. Solid dispersions of (r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide
DK3601277T3 (da) * 2017-03-30 2024-01-15 Merck Patent Gmbh Farmaceutisk formulering
US20180282527A1 (en) * 2017-03-30 2018-10-04 Shin-Etsu Chemical Co., Ltd. Injection molding composition containing hypromellose acetate succinate and method for producing same
CN109512787A (zh) * 2018-12-07 2019-03-26 天津国际生物医药联合研究院 一种维生素b12固体分散体及其制备方法
JP7050714B2 (ja) 2019-04-04 2022-04-08 信越化学工業株式会社 腸溶性コーティング用組成物及び固形製剤の製造方法
US20210128536A1 (en) * 2019-11-01 2021-05-06 Dispersol Technologies, Llc Weakly basic drug and ionic polymer pharmaceutical formulations and methods of formation and administration thereof
CN114948879B (zh) * 2022-04-19 2024-02-02 河北农业大学 一种灰黄霉素固体分散体及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226981A (en) 1977-09-28 1980-10-07 Shin-Etsu Chemical Co., Ltd. Ether-ester derivatives of cellulose and their applications
JPS5951562B2 (ja) 1977-10-25 1984-12-14 信越化学工業株式会社 セルロ−スエ−テルの酸性サクシニルおよび脂肪族モノアシル混成エステルの製造方法
ES2287971T3 (es) 1997-08-11 2007-12-16 Pfizer Products Inc. Dispersiones farmaceuticas solidas con biodisponibilidad incrementada.
KR20030041577A (ko) * 2001-11-20 2003-05-27 디디에스텍주식회사 난용성 약물과 치환된 시클로덱스트린을 함유하는고체분산체 및 이를 함유하는 약제학적 조성물
JP2004067606A (ja) 2002-08-08 2004-03-04 Zensei Yakuhin Kogyo Kk イトラコナゾール経口投与製剤
US8207232B2 (en) * 2004-05-28 2012-06-26 Bend Research, Inc. Pharmaceutical compositions with enhanced performance
WO2006082518A1 (en) * 2005-02-03 2006-08-10 Pfizer Products Inc. Pharmaceutical compositions with enhanced performance
CN101120922B (zh) * 2006-08-08 2012-04-11 信越化学工业株式会社 肠溶固体分散体的固体制剂及其制备方法
US8343548B2 (en) * 2006-08-08 2013-01-01 Shin-Etsu Chemical Co., Ltd. Solid dosage form comprising solid dispersion
JP4852443B2 (ja) 2007-02-21 2012-01-11 株式会社アイテック 成形体
US20110034478A1 (en) 2008-04-15 2011-02-10 Schering-Plough Corporation Oral Pharmaceutical Compositions in a Solid Dispersion Comprising Preferably Posaconazole and HPMCAs
EP2354825B1 (en) 2010-02-03 2015-07-15 Tyco Electronics Nederland B.V. Enclosure assembly for a connector, strain relief element, and method
WO2011159626A1 (en) 2010-06-14 2011-12-22 Bend Research, Inc. Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution
WO2012051035A1 (en) 2010-10-12 2012-04-19 Dow Global Technologies Llc Novel cellulose ethers and their use
US20120251588A1 (en) * 2011-03-30 2012-10-04 Miyuki Fukasawa Coating Composition, Solid Preparation Coated Therewith, and Method for Preparing Solid Preparation
JP2013116836A (ja) 2011-12-02 2013-06-13 Sharp Corp シリコン端材の再利用方法並びに原料シリコン、多結晶シリコン材料及び多結晶シリコン太陽電池の製造方法
EP2836205B1 (en) * 2012-04-11 2016-10-19 Dow Global Technologies LLC Esterified cellulose ethers having a specific substituent distribution
EP2888289B1 (en) * 2012-08-24 2019-08-07 Dow Global Technologies LLC Partially cross-linked esterified cellulose ethers
WO2014031422A1 (en) 2012-08-24 2014-02-27 Dow Global Technologies Llc Novel hydroxyalkyl methyl cellulose acetate succinates
KR102029167B1 (ko) 2012-08-28 2019-10-08 주식회사 그루버스 사용자 상황에 따른 음악감상 서비스 시스템 및 방법
JP5836980B2 (ja) * 2013-01-11 2015-12-24 信越化学工業株式会社 薬物含有粒子、固形製剤及び薬物含有粒子の製造方法
JP2014233774A (ja) † 2013-05-31 2014-12-15 株式会社荏原製作所 ロボットアーム制御装置、基板搬送装置、基板処理装置、ロボットアーム制御方法およびプログラム
IN2014DE01467A (pt) * 2013-06-03 2015-07-24 Shinetsu Chemical Co
EP2837391B1 (en) * 2013-08-12 2017-05-10 Shin-Etsu Chemical Co., Ltd. Hypromellose acetate succinate for use as hot-melt extrusion carrier, hot-melt extrusion composition, and method for producing hot-melt extrudate

Also Published As

Publication number Publication date
EP3023110B1 (en) 2017-08-16
EP3023110B2 (en) 2023-09-27
KR20210002091A (ko) 2021-01-06
US20160136283A1 (en) 2016-05-19
US10493161B2 (en) 2019-12-03
EP3023110A1 (en) 2016-05-25
JP2016098179A (ja) 2016-05-30
KR20160059427A (ko) 2016-05-26
JP6203702B2 (ja) 2017-09-27
CN105597103B (zh) 2021-06-11
KR102315569B1 (ko) 2021-10-21
CN105597103A (zh) 2016-05-25

Similar Documents

Publication Publication Date Title
ZA202106267B (en) Apparatus and method for spray drying
PT3023110T (pt) Solução para secagem por pulverização que compreende acetato succinato de hipromelose e método para produzir dispersão sólida
ZA201800637B (en) Methyl acetate preparation method
EP3238549A4 (en) Dried noodles and production method thereof
EP3169941A4 (en) Ventilation and drying system and method of using the same
SI3167011T1 (sl) Postopek sušenja
EP3237556A4 (en) Microparticles and apparatus for smart ink production
EP3222950A4 (en) Coat drying device and coat drying method
HK1243995A1 (zh) α-細辛醇酯及其製備方法與應用
EP3349831A4 (en) SYSTEM AND METHOD FOR DRY POWDER DISPENSING
SG11201610920WA (en) An improved thermostable spray dried rotavirus vaccine formulation and process thereof
PL3164017T4 (pl) Powlekana rolka sushi oraz sposób jej wytwarzania i przygotowywania
EP3222951A4 (en) Coat drying device and coat drying method
EP3232147A4 (en) Container-interior drying device and container-interior drying method
EP3162437A4 (en) Catalyst for synthesizing theaflavin and method for synthesizing theaflavin
GB2524581B (en) Room drying apparatus and method
HK1232209A1 (zh) 製備 -乙酰氧基丙酸及其衍生物的方法
EP3190417A4 (en) Polymer microparticle for carrying physiologically active substance and method for preparing same
GB201417674D0 (en) Spray Drier Apparatus
EP3112445A4 (en) Method for manufacturing dried combustible substance and dried combustible substance
IL253175B (en) A process for the preparation of ospemifene and fispemifene
AU2014904649A0 (en) Drying Apparatus and Related Method
GB201410851D0 (en) Drying apparatus, system and method
GB201416155D0 (en) System and process